Researchers are saying that, from an infection control perspective, C. auris acts more like a multidrug-resistant, healthcare-associated bacteria than like a typical yeast, according to an article on the MedPage website.
"It is a new bug using old tricks mastered by some well-known, multidrug resistant organisms," they said.
Identifying, treating, and preventing Candida auris is a challenge facing more and more healthcare settings.
Findings presented at the 2019 ASM Microbe meeting in San Francisco by researchers from the Centers for Disease Control and Prevention found that patients with C. auris appear to "shed" the pathogen from their skin into their environment, which could potentially play a factor in transmission.
The Top Three Pathogens to Worry About in 2026
Blackbird Health Opens New Pediatric Mental Health Clinic in Virginia
Baptist Medical Center Jacksonville to Get Inpatient Rehabilitation Unit
Building Envelopes Emerge As Key Facility Components
Catholic Medical Center Breaks Ground on New Central Energy Plant